Dietary acrylamide and human cancer: A systematic review of literature

Nutrition and Cancer

Volumn 66, Issue 5, 2014, Pages 774-790

  Virk Baker, Mandeep K ^a   Nagy, Tim R ^b   Barnes, Stephen ^c   Groopman, John ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; AMINO ACID; ASPARAGINE; CARCINOGEN; FRUCTOSE; GLUCOSE; ALPHA TOCOPHEROL; BETA CAROTENE;

CANCER PREVENTION; CANCER RISK; CARCINOGENICITY; CAUSE OF DEATH; COOKED FOOD; DIETARY INTAKE; ENDOMETRIUM CANCER; EXPOSURE; GLYCATION; HUMAN; KIDNEY CANCER; OVARY CANCER; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; UNITED STATES; ANIMAL; DIET; DISEASE MODEL; DOSE RESPONSE; EPIDEMIOLOGY; EVIDENCE BASED PRACTICE; FEMALE; MALE; NEOPLASMS; TOXICITY;

ANIMALIA;

ACRYLAMIDE; ALPHA-TOCOPHEROL; ANIMALS; BETA CAROTENE; CARCINOGENS; DIET; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDEMIOLOGIC STUDIES; EVIDENCE-BASED PRACTICE; FEMALE; HUMANS; MALE; NEOPLASMS;

EID: 84903271808     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.916323     Document Type: Review

References (83)

1. Tareke E., Rydberg P., Karlsson P., Eriksson S., and Tornqvist M.: Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 50, 4998-5006, 2002.
2. Mottram DS., Wedzicha BL., and Dodson AT.: Acrylamide is formed in the Maillard reaction. Nature 419, 448-449, 2002.
3. Stadler RH., Blank I., Varga N., Robert F., Hau J, et al.: Acrylamide from Maillard reaction products. Nature 419, 449-450, 2002.
4. Elmore JS., Koutsidis G., Dodson AT., Mottram DS., and Wedzicha BL.: The effect of cooking on acrylamide and its precursors in potato, wheat and rye. Adv Exp Med Biol 561, 255-269, 2005.
5. Ishihara K., Matsunaga A., Miyoshi T., Nakamura K., Nakayama T, et al.: Formation of acrylamide in a processed food model system, and examination of inhibitory conditions. Shokuhin Eiseigaku Zasshi 46, 33-39, 2005.
6. Lukac H., Amrein TM., Perren R., Conde-Petit B., Amado R, et al.: Influence of roasting conditions on the acrylamide content and the color of roasted almonds. J Food Sci 72, C033-C038, 2007.
7. Amrein TM., Bachmann S., Noti A., Biedermann M., Barbosa MF, et al.: Potential of acrylamide formation, sugars, and free asparagine in potatoes: a comparison of cultivars and farming systems. J Agric Food Chem 51, 5556-5560, 2003.
8. De WT., De MB., Mestdagh F., Govaert Y., Vandeburie S, et al.: Influence of fertilization on acrylamide formation during frying of potatoes harvested in 2003. J Agric Food Chem 54, 404-408, 2006.
9. Chuda Y., Ono H., Yada H., Ohara-Takada A., Matsuura-Endo C, et al.: Effects of physiological changes in potato tubers (Solanum tuberosum L.). after low temperature storage on the level of acrylamide formed in potato chips. Biosci Biotechnol Biochem 67, 1188-1190, 2003.
10. Biedermann-Brem S., Noti A., Grob K., Imhof D., Bazzacco D, et al.: How much reducing sugar may potatoes contain to aviod excessive acrylamide formation during roasting and baking? Eur Food Res Technol 217, 369-373, 2003.
11. Hogervorst JG., Schouten LJ., Konings EJ., Goldbohm RA., and van den Brandt PA.: A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomarkers Prev 16, 2304-2313, 2007.
12. Larsson SC., Akesson A., and Wolk A.: Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men. Cancer Epidemiol Biomarkers Prev 18, 1939-1941, 2009.
13. Larsson SC., Akesson A., and Wolk A.: Long-term dietary acrylamide intake and breast cancer risk in a prospective cohort of Swedish women. Am J Epidemiol 169, 376-381, 2009.
14. Larsson SC., Akesson A., and Wolk A.: Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Cancer Epidemiol Biomarkers Prev 18, 994-997, 2009.
15. Larsson SC., Hakansson N., Akesson A., and Wolk A.: Long-term dietary acrylamide intake and risk of endometrial cancer in a prospective cohort of Swedish women. Int J Cancer 124, 1196-1199, 2009.
16. Mucci LA., Sandin S., Balter K., Adami HO., Magnusson C, et al.: Acrylamide intake and breast cancer risk in Swedish women. JAMA 293, 1326-1327, 2005.
17. Pedersen GS., Hogervorst JG., Schouten LJ., Konings EJ., Goldbohm RA, et al.: Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk. Breast Cancer Res Treat 122, 199-210, 2010.
18. Pelucchi C., Galeone C., Levi F., Negri E., Franceschi S, et al.: Dietary acrylamide and human cancer. Int J Cancer 118, 467-471, 2006.
19. Wilson KM., Mucci LA., Cho E., Hunter DJ., Chen WY, et al.: Dietary acrylamide intake and risk of premenopausal breast cancer. Am J Epidemiol 169, 954-961.
20. Hogervorst JG., Schouten LJ., Konings EJ., Goldbohm RA., van den Brandt PA. Dietary acrylamide intake is not associated with gastrointestinal cancer risk. J Nutr 138, 2229-2236, 2008.
21. Larsson SC., Akesson A., Bergkvist L., and Wolk A.: Dietary acrylamide intake and risk of colorectal cancer in a prospective cohort of men. Eur J Cancer 45, 513-516, 2009.
22. Mucci LA., Dickman PW., Steineck G., Adami HO., and Augustsson K.: Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer 88, 84-89, 2003.
23. Mucci LA., Adami HO., and Wolk A.: Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int J Cancer 118, 169-173, 2006.
24. Hogervorst JG., Schouten LJ., Konings EJ., Goldbohm RA., and van den Brandt PA.: Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am J Clin Nutr 87, 1428-1438, 2008.
25. Mucci LA., Lindblad P., Steineck G., and Adami HO.: Dietary acrylamide and risk of renal cell cancer. Int J Cancer 109, 774-776, 2004.
26. Pelucchi C., Galeone C., Dal ML., Talamini R., Montella M, et al.: Dietary acrylamide and renal cell cancer. Int J Cancer 120, 1376-1377, 2007.
27. Hogervorst JG., Schouten LJ., Konings EJ., Goldbohm RA., and van den Brandt PA. Lung cancer risk in relation to dietary acrylamide intake. J Natl Cancer Inst 101, 651-662, 2009.
28. Hogervorst JG., Schouten LJ., Konings EJ., Goldbohm RA., and van den Brandt PA.: Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol Biomarkers Prev 18, 1663-1666, 2009.
29. Olesen PT., Olsen A., Frandsen H., Frederiksen K., Overvad K, et al.: Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study. Int J Cancer 122, 2094-2100, 2008.
30. Wilson KM., Balter K., Adami HO., Gronberg H., Vikstrom AC, et al.: Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study. Int J Cancer 124, 2384-2390, 2009.
31. Mucci LA. and Wilson KM.: Acrylamide intake through diet and human cancer risk. J Agric Food Chem 56, 6013-6019, 2008.
32. U.S. Food. and Drug Administration.: Survey Data on Acrylamide in Food: Total Diet Study. Revitrieved from http://www.fda.govov/Food/FoodSafety/ FoodContaminantsAdulteration/ChemicalContaminants/Acrylamide/ucm053566htm2004
33. U.S. Food. and Drug Administration.: Survey Data on Acrylamide in Food: Individual Food Products. Retrieved from http://www.fda.gov/Food/FoodSafety/ FoodContaminantsAdulteration/ChemicalContamiChems/Acrylamide/ucm053549.htm#u1004
34. Fuhr U., Boettcher MI., Kinzig-Schippers M., Weyer A., Jetter A, et al.: Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 15, 266-271, 2006.
35. Hogervorst JG., Baars BJ., Schouten LJ., Konings EJ., Goldbohm RA, et al.: The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit Rev Toxicol 40, 485-512, 2010.
36. Pelucchi C., La VC., Bosetti C., Boyle P., and Boffetta P.: Exposure to acrylamide and human cancer-A review and meta-analysis of epidemiologic studies. Ann Oncol 7, 1487-1499, 2011.
37. Fennell TR., Sumner SC., Snyder RW., Burgess J., Spicer R, et al.: Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci 85, 447-459, 2005.
38. Fennell TR., Sumner SC., Snyder RW., Burgess J., and Friedman MA.: Kinetics of elimination of urinary metabolites of acrylamide in humans. Toxicol Sci 93, 256-267, 2006.
39. Bergmark E., Calleman CJ., and Costa LG.: Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol Appl Pharmacol 111, 352-363, 1991.
40. Bergmark E., Calleman CJ., He F., and Costa LG.: Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. T oxicol Appl Pharmacol 120, 45-54, 1993.
41. Sumner SC., Fennell TR., Moore TA., Chanas B., Gonzalez F, et al.: Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 12, 1110-1116, 1999.
42. Taubert D., Glockner R., Muller D., and Schomig E.: The garlic ingredient diallyl sulfide inhibits cytochrome P450 2E1 dependent bioactivation of acrylamide to glycidamide. Toxicol Lett 164, 1-5, 2006.
43. Ghanayem BI., Witt KL., Kissling GE., Tice RR., and Recio L.: Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect. Mutat Res 578, 284-297, 2005.
44. Fennell TR., Sumner SC., and Walker VE.: A model for the formation and removal of hemoglobin adducts. Cancer Epidemiol Biomarkers Prev 1, 213-219, 1992.
45. Schettgen T., Rossbach B., Kutting B., Letzel S., Drexler H, et al.: Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. Int J Hyg Environ Health 207, 531-539, 2004.
46. Urban M., Kavvadias D., Riedel K., Scherer G., and Tricker AR.: Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal Toxicol 18, 831-839, 2006.
47. Vesper HW., Caudill SP., Osterloh JD., Meyers T., Scott D, et al.: Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004. Environ Health Perspect 118, 278-283, 2010.
48. Dybing E., Farmer PB., Andersen M., Fennell TR., Lalljie SP, et al.: Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol 43, 365-410, 2005.
49. Svensson K., Abramsson L., Becker W., Glynn A., Hellenas KE, et al.: Dietary intake of acrylamide in Sweden. Food Chem Toxicol 41, 1581-1586, 2003.
50. Konings EJ., Baars AJ., van Klaveren JD., Spanjer MC., Rensen PM, et al.: Acrylamide exposure from foods of the Dutch population and an assessment of the consequent risks. Food Chem Toxicol 41, 1569-1579, 2003.
51. Schettgen T., Kutting B., Hornig M., Beckmann MW., Weiss T, et al.: Trans-placental exposure of neonates to acrylamide-A pilot study. Int Arch Occup Environ Health 77, 213-216, 2004.
52. Magnus P., Irgens LM., Haug K., Nystad W., Skjaerven R, et al.: Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 35, 1146-1150, 2006.
53. Kutting B., Uter W., and Drexler H.: The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure. Cancer Causes Control 19, 273-281, 2008.
54. Ferrari P., Freisling H., Duell EJ., Kaaks R., Lujan-Barroso L, et al.: Challenges in estimating the validity of dietary acrylamide measurements. Eur J Nutr 5, 1503-1512, 2013.
55. Riboli E., Hunt KJ., Slimani N., Ferrari P., Norat T, et al.: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5, 1113-1124, 2002.
56. Wilson KM., Mucci LA., Rosner BA., and Willett WC.: A prospective study of dietary acrylamide intake and the risk of breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev 10, 2503-2515, 2010.
57. Hirvonen T., Kontto J., Jestoi M., Valsta L., Peltonen K, et al.: Dietary acrylamide intake and the risk of cancer among Finnish male smokers. Cancer Causes Control 21, 2223-2229, 2010.
58. Satia JA., Littman A., Slatore CG., Galanko JA., and White E.: Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 169, 815-828, 2009.
59. Slatore CG., Littman AJ., Au DH., Satia JA., and White E.: Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med 177, 524-530, 2008.
60. Wright ME., Groshong SD., Husgafvel-Pursiainen K., Genova E., Lucia MS, et al.: Effects of beta-carotene supplementation on molecular markers of lung carcinogenesis in male smokers. Cancer Prev Res (Phila) 3, 745-752, 2010.
61. Wilson KM., Giovannucci E., Stampfer MJ., and Mucci LA.: Dietary acrylamide and risk of prostate cancer. Int J Cancer 131, 479-487, 2012.
62. van den Brandt PA., Goldbohm RA., van't Veer P., Volovics A., Hermus RJ, et al.: A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol 43, 285-295, 1990.
63. Schouten LJ., Hogervorst JG., Konings EJ., Goldbohm RA., and van den Brandt PA.: Dietary acrylamide intake and the risk of head-neck and thyroid cancers: results from the Netherlands Cohort Study. Am J Epidemiol 170, 873-884, 2009.
64. Bongers ML., Hogervorst JG., Schouten LJ., Goldbohm RA., Schouten HC, et al. Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer. PLoS One 7 (6 2012.
65. Cade JE., Burley VJ., and Greenwood DC.: The UK Women's Cohort Study: comparison of vegetarians, fish-eaters and meat-eaters. Public Health Nutr 7, 871-878, 2004.
66. Burley VJ., Greenwood DC., Hepworth SJ., Fraser LK., de Kok TM, et al.: Dietary acrylamide intake and risk of breast cancer in the UK women's cohort. Br J Cancer 103, 1749-1754, 2010.
67. Tjonneland A., Olsen A., Boll K., Stripp C., Christensen J, et al.: Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35, 432-441, 2007.
68. Xie J., Terry KL., Poole EM., Wilson KM., Rosner BA, et al.: Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study. Cancer Epidemiol Biomarkers Prev 22, 653-660, 2013.
69. Augustsson K., Skog K., Jagerstad M., Dickman PW., and Steineck G.: Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study. Lancet 353, 703-707, 1999.
70. Augustsson K., Skog K., Jagerstad M., and Steineck G.: Assessment of the human exposure to heterocyclic amines. Carcinogenesis 18, 1931-1935, 1997.
71. Hagmar L. and Tornqvist M.: Inconclusive results from an epidemiological study on dietary acrylamide and cancer. Br J Cancer 89, 774-775, 2003.
72. Lindblad P., Wolk A., Bergstrom R., and Adami HO.: Diet and risk of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 6, 215-223, 1997.
73. Hedelin M., Balter KA., Chang ET., Bellocco R., Klint A, et al.: Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 66, 1512-1520, 2006.
74. Lin Y., Lagergren J., and Lu Y.: Dietary acrylamide intake and risk of esophageal cancer in a population-based case-control study in Sweden. Int J Cancer 128, 676-681, 2011.
75. Lagergren J., Bergstrom R., Lindgren A., and Nyren O.: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340, 825-831, 1999.
76. Pelucchi C., Franceschi S., Levi F., Trichopoulos D., Bosetti C, et al.: Fried potatoes and human cancer. Int J Cancer 105, 558-560, 2003.
77. Soler M., Bosetti C., Franceschi S., Negri E., Zambon P, et al.: Fiber intake and the risk of oral, pharyngeal and esophageal cancer. Int J Cancer 91, 283-287, 2001.
78. Levi F., Pasche C., Lucchini F., Chatenoud L., Jacobs DR, et al.: Refined and whole grain cereals and the risk of oral, oesophageal and laryngeal cancer. Eur J Clin Nutr 54, 487-489, 2000.
79. Bosetti C., La VC., Talamini R., Negri E., Levi F, et al.: Food groups and laryngeal cancer risk: a case-control study from Italy and Switzerland. Int J Cancer 100, 355-360, 2002.
80. La VC., Braga C., Negri E., Franceschi S., Russo A, et al.: Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer 73, 525-530, 1997.
81. Tavani A., Gallus S., La VC., Dal ML., Negri E, et al.: Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer 91, 407-411, 2001.
82. Franceschi S., Favero A., Decarli A., Negri E., La VC, et al.: Intake of macronutrients and risk of breast cancer. Lancet 347, 1351-1356, 1996.
83. Pelucchi C., Galeone C., Talamini R., Negri E., Polesel J, et al.: Dietary acrylamide and pancreatic cancer risk in an Italian case-control study. Ann Oncol 22, 1910-1915, 2011.